A biotech superstar with UNTHSC roots
By Jan Jarvis
Six years ago in an acceleration lab at UNT Health Science Center, the co-founders of ZS Pharma were developing a drug that they believed held great promise. But even with such lofty expectations, ZS Pharma co-founders Alvaro Guillem and Jeff Keyser may have underestimated their biotech startup’s potential.
Earlier this month British drug maker AstraZeneca agreed to acquire ZS Pharma for $2.7 billion in cash.
In the pharmaceutical world – where it typically takes a decade or more to move a drug from bench to bedside – ZS Pharma has moved at lightning speed. UNT Health Science Center helped make it all possible by providing offices, conference rooms and a lab where much of the work was done, Guillem said.
“During the early years it was critical to have the support of institutions like UNTHSC and the accelerator labs to be able to move the project forward,” Guillem said. “To this day, we continue to collaborate with labs and rely on their equipment and expertise to address various technical topics.”
From the start, ZS Pharma had all the making of a biotech superstar. Founded in 2008, it debuted on Wall Street as the first biotech IPO in Texas since 2000. Its drug, called ZS-9, has been on the fast track from the start.
Multiple clinical trials have shown the effectiveness of the drug, which is expected to hit the market in 2016. It treats hyperkalemia, a potentially life-threatening disease caused by excess potassium. About one in 200,000 people have the condition, which often affects people with chronic kidney disease and chronic heart failure.
Since 2006, UNT Health Science Center’s Office of Research Development and Commercialization and TECH Fort Worth, a non-profit technology incubator, have worked in partnership to bring new technologies to the market.
Firms get a boost from the UNTHSC Accelerator Lab Program along with the Executives-in-Residence, who act as mentors and offer advice from their years of experience in the pharmaceutical industry.
Taking research to the marketplace can be an arduous process. Playing a part in getting this drug on the path to patients has been rewarding for everyone involved , said Lawrence “Joe” Allred, Associate Vice President for Research and Innovation at UNTHSC.
“We can rightfully take pride in ZS Pharma’s success as a graduation of incubation in our Accelerator Labs,” he said.
By Sally Crocker UNTHSC students, faculty and staff are invited to the 2nd Annual Zoonotic Disease Fair from noon to 3 p.m. on Nov. 21 to learn about some of the common diseases found in Texas that can be passed from animals to humans. “It pays to be aware,” said public health st...Read more
Nov 16, 2017
By Alex Branch Amy Raines Milenkov, MPH, DrPH, has always cared about the underdog. She cared about the low-income women and children afflicted with HIV or AIDS who she helped as a social worker in the 1990s, when life-saving drug cocktails were only emerging. She cared for the vu...Read more
Nov 13, 2017
By Jan Jarvis Catherine Daniel, a first-year student in the Texas College of Osteopathic Medicine, clicked on the keys of her laptop, searching for data about a program to address infant mortality in Tarrant County. “There needs to be a better way of identifying high risk people,” she ...Read more
Nov 13, 2017
By Alex Branch Gary and Aundrea Palladino met while serving in the U.S. Air Force as pharmacy technicians at Joint Base Andrews in Washington, D.C. At the three pharmacies on base, Gary and Aundrea filled prescriptions and managed inventory, compounded IV and topical medication orders, and...Read more
Nov 9, 2017